Bardey, David, De Donder, Philippe and Mantilla, Cesar (2019) How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment. Journal of Health Economics, 68. p. 102223.

This is the latest version of this item.

[thumbnail of wp_tse_777.pdf]
Preview
Text
Download (2MB) | Preview
Identification Number : 10.1016/j.jhealeco.2019.102223

Abstract

We develop a theoretical analysis of two widely used regulations of genetic
tests, Disclosure Duty and Consent Law, and we run an experiment in order
to shed light on both the take-up rate of genetic testing and on the comparison of policyholders’ welfare under the two regulations. Disclosure duty
forces individuals to reveal their test results to insurers, exposing them to a
discrimination risk. Consent law allows them to hide any detrimental information, resulting in adverse selection. The experiment results in much lower
genetic tests take-up rates with Disclosure Duty than with Consent Law,
showing that subjects are very sensitive to the discrimination risk. Under
Consent Law, take-up rates increase with the adverse selection intensity. A
decrease in the test cost, and in adverse selection intensity, both make it
more likely that Consent Law is preferred to Disclosure Duty.

Item Type: Article
Language: English
Date: December 2019
Refereed: Yes
Uncontrolled Keywords: Consent Law, Disclosure Duty, Personalized Medicine, Test, take-up rate, pooling health insurance contracts.
JEL Classification: C91 - Laboratory, Individual Behavior
D82 - Asymmetric and Private Information
I18 - Government Policy; Regulation; Public Health
Subjects: B- ECONOMIE ET FINANCE
Divisions: TSE-R (Toulouse)
Site: UT1
Date Deposited: 27 Aug 2019 09:25
Last Modified: 27 Oct 2021 13:37
OAI Identifier: oai:tse-fr.eu:123305
URI: https://publications.ut-capitole.fr/id/eprint/32693

Available Versions of this Item

View Item

Downloads

Downloads per month over past year